Suppr超能文献

ALS 伴 FTLD 患者病理性 TDP-43 纤维的结构。

Structure of pathological TDP-43 filaments from ALS with FTLD.

机构信息

MRC Laboratory of Molecular Biology, Cambridge, UK.

Department of Brain and Neurosciences, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.

出版信息

Nature. 2022 Jan;601(7891):139-143. doi: 10.1038/s41586-021-04199-3. Epub 2021 Dec 8.

Abstract

The abnormal aggregation of TAR DNA-binding protein 43 kDa (TDP-43) in neurons and glia is the defining pathological hallmark of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and multiple forms of frontotemporal lobar degeneration (FTLD). It is also common in other diseases, including Alzheimer's and Parkinson's. No disease-modifying therapies exist for these conditions and early diagnosis is not possible. The structures of pathological TDP-43 aggregates are unknown. Here we used cryo-electron microscopy to determine the structures of aggregated TDP-43 in the frontal and motor cortices of an individual who had ALS with FTLD and from the frontal cortex of a second individual with the same diagnosis. An identical amyloid-like filament structure comprising a single protofilament was found in both brain regions and individuals. The ordered filament core spans residues 282-360 in the TDP-43 low-complexity domain and adopts a previously undescribed double-spiral-shaped fold, which shows no similarity to those of TDP-43 filaments formed in vitro. An abundance of glycine and neutral polar residues facilitates numerous turns and restricts β-strand length, which results in an absence of β-sheet stacking that is associated with cross-β amyloid structure. An uneven distribution of residues gives rise to structurally and chemically distinct surfaces that face external densities and suggest possible ligand-binding sites. This work enhances our understanding of the molecular pathogenesis of ALS and FTLD and informs the development of diagnostic and therapeutic agents that target aggregated TDP-43.

摘要

TDP-43 蛋白的异常聚集是神经退行性疾病肌萎缩性侧索硬化症(ALS)和多种额颞叶变性(FTLD)的特征性病理标志。它也常见于其他疾病,包括阿尔茨海默病和帕金森病。目前尚无针对这些疾病的治疗方法,也无法进行早期诊断。病理性 TDP-43 聚集体的结构尚不清楚。在这里,我们使用冷冻电镜来确定来自患有 ALS 和 FTLD 的个体额叶和运动皮层以及来自另一名具有相同诊断的个体额叶中聚集的 TDP-43 的结构。在这两个大脑区域和个体中,均发现了由一个原纤维组成的相同的淀粉样纤维结构。有序的纤维核心跨越 TDP-43 低复杂度结构域中的残基 282-360,并采用了以前未描述的双螺旋折叠,与体外形成的 TDP-43 纤维没有相似之处。甘氨酸和中性极性残基的丰富程度促进了大量的转折并限制了β-链长度,从而导致缺乏与交叉-β淀粉样结构相关的β-片层堆叠。残基的不均匀分布导致了结构和化学上不同的表面,这些表面与外部密度相对应,并提示可能的配体结合位点。这项工作增强了我们对 ALS 和 FTLD 分子发病机制的理解,并为开发针对聚集 TDP-43 的诊断和治疗药物提供了信息。

相似文献

1
Structure of pathological TDP-43 filaments from ALS with FTLD.ALS 伴 FTLD 患者病理性 TDP-43 纤维的结构。
Nature. 2022 Jan;601(7891):139-143. doi: 10.1038/s41586-021-04199-3. Epub 2021 Dec 8.
6
TAF15 amyloid filaments in frontotemporal lobar degeneration.TAF15 淀粉样纤维在额颞叶变性中的作用。
Nature. 2024 Jan;625(7994):345-351. doi: 10.1038/s41586-023-06801-2. Epub 2023 Dec 6.

引用本文的文献

2
Discovery of RNA-Targeting Small Molecules: Challenges and Future Directions.RNA靶向小分子的发现:挑战与未来方向
MedComm (2020). 2025 Aug 24;6(9):e70342. doi: 10.1002/mco2.70342. eCollection 2025 Sep.
8
Emergence of Compact Oligomers inside the Small-World Network of TDP-43 Condensates.TDP-43凝聚物小世界网络内紧密寡聚体的出现。
J Phys Chem Lett. 2025 Aug 7;16(31):7797-7806. doi: 10.1021/acs.jpclett.5c01627. Epub 2025 Jul 25.

本文引用的文献

1
Cryo-EM single-particle structure refinement and map calculation using Servalcat.使用 Servalcat 进行冷冻电镜单颗粒结构精修和映射计算。
Acta Crystallogr D Struct Biol. 2021 Oct 1;77(Pt 10):1282-1291. doi: 10.1107/S2059798321009475. Epub 2021 Sep 29.
2
Structure-based classification of tauopathies.基于结构的tau 病分类。
Nature. 2021 Oct;598(7880):359-363. doi: 10.1038/s41586-021-03911-7. Epub 2021 Sep 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验